Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(30%)
Results Posted
100%(4 trials)

Phase Distribution

Ph not_applicable
1
10%
Ph phase_3
3
30%
Ph phase_1
1
10%
Ph phase_2
2
20%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
3(42.9%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(5)
Completed(4)
Other(1)

Detailed Status

Completed4
Active, not recruiting3
Enrolling by invitation2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 22 (28.6%)
Phase 33 (42.9%)
N/A1 (14.3%)

Trials by Status

completed440%
active_not_recruiting330%
enrolling_by_invitation220%
unknown110%

Recent Activity

Clinical Trials (10)

Showing 10 of 10 trials

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10